Antibody derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10202447
APP PUB NO 20160194391A1
SERIAL NO

14886978

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates inter alia to a bivalent, bispecific construct comprising an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof and its use in therapy. The invention also relates to useful anti-IL-6 antibodies and anti-IL-23 antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MEDIMMUNE LIMITED

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brady, William Seattle, US 53 2494
Grabstein, Kenneth Seattle, US 6 114
King, Gordon Seattle, US 21 207
Nairn, Natalie Winblade Seattle, US 18 131
Shanebeck, Kurt David Seattle, US 2 43
Slagle, Paul Heffner Seattle, US 2 43
Thornton, Kenneth Christopher Seattle, US 2 43
Vanbrunt, Michael Peter Seattle, US 2 43
Wang, Andrea Seattle, US 5 65
Xu, Hengyu Seattle, US 4 43

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 12, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 12, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00